GERN vs. RMD
Compare and contrast key facts about Geron Corporation (GERN) and ResMed Inc. (RMD).
Performance
GERN vs. RMD - Performance Comparison
Loading graphics...
GERN vs. RMD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GERN Geron Corporation | 12.88% | -62.71% | 67.77% | -12.81% | 98.36% | -23.27% | 16.91% | 36.00% | -44.44% | -13.04% |
RMD ResMed Inc. | -6.59% | 6.26% | 34.18% | -16.55% | -19.47% | 23.41% | 38.33% | 37.85% | 36.38% | 39.06% |
Fundamentals
GERN:
-$0.13
RMD:
$15.16
GERN:
5.40
RMD:
4.08
GERN:
$183.88M
RMD:
$5.40B
GERN:
$158.07M
RMD:
$3.29B
GERN:
-$39.32M
RMD:
$1.96B
Returns By Period
In the year-to-date period, GERN achieves a 12.88% return, which is significantly higher than RMD's -6.59% return. Over the past 10 years, GERN has underperformed RMD with an annualized return of -6.76%, while RMD has yielded a comparatively higher 15.62% annualized return.
GERN
- 1D
- 5.67%
- 1M
- -11.31%
- YTD
- 12.88%
- 6M
- 8.76%
- 1Y
- -6.29%
- 3Y*
- -11.78%
- 5Y*
- -1.66%
- 10Y*
- -6.76%
RMD
- 1D
- 2.02%
- 1M
- -12.40%
- YTD
- -6.59%
- 6M
- -17.61%
- 1Y
- 1.18%
- 3Y*
- 1.78%
- 5Y*
- 3.81%
- 10Y*
- 15.62%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GERN vs. RMD — Risk / Return Rank
GERN
RMD
GERN vs. RMD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Geron Corporation (GERN) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GERN | RMD | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.09 | 0.05 | -0.14 |
Sortino ratioReturn per unit of downside risk | 0.36 | 0.26 | +0.11 |
Omega ratioGain probability vs. loss probability | 1.04 | 1.03 | +0.01 |
Calmar ratioReturn relative to maximum drawdown | -0.29 | 0.12 | -0.41 |
Martin ratioReturn relative to average drawdown | -0.53 | 0.28 | -0.81 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| GERN | RMD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.09 | 0.05 | -0.14 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.02 | 0.12 | -0.14 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.09 | 0.50 | -0.59 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.06 | 0.53 | -0.60 |
Correlation
The correlation between GERN and RMD is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
GERN vs. RMD - Dividend Comparison
GERN has not paid dividends to shareholders, while RMD's dividend yield for the trailing twelve months is around 1.04%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GERN Geron Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RMD ResMed Inc. | 1.04% | 0.94% | 0.88% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% |
Drawdowns
GERN vs. RMD - Drawdown Comparison
The maximum GERN drawdown since its inception was -98.73%, which is greater than RMD's maximum drawdown of -61.61%. Use the drawdown chart below to compare losses from any high point for GERN and RMD.
Loading graphics...
Drawdown Indicators
| GERN | RMD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.73% | -61.61% | -37.12% |
Max Drawdown (1Y)Largest decline over 1 year | -33.95% | -24.74% | -9.21% |
Max Drawdown (5Y)Largest decline over 5 years | -78.98% | -53.99% | -24.99% |
Max Drawdown (10Y)Largest decline over 10 years | -86.09% | -53.99% | -32.10% |
Current DrawdownCurrent decline from peak | -97.87% | -23.22% | -74.65% |
Average DrawdownAverage peak-to-trough decline | -86.08% | -15.91% | -70.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.29% | 10.55% | +7.74% |
Volatility
GERN vs. RMD - Volatility Comparison
Geron Corporation (GERN) has a higher volatility of 21.18% compared to ResMed Inc. (RMD) at 6.17%. This indicates that GERN's price experiences larger fluctuations and is considered to be riskier than RMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| GERN | RMD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.18% | 6.17% | +15.01% |
Volatility (6M)Calculated over the trailing 6-month period | 46.58% | 17.04% | +29.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 67.84% | 25.62% | +42.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 82.34% | 31.07% | +51.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.96% | 31.41% | +46.55% |
Financials
GERN vs. RMD - Financials Comparison
This section allows you to compare key financial metrics between Geron Corporation and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GERN vs. RMD - Profitability Comparison
GERN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Geron Corporation reported a gross profit of 46.71M and revenue of 48.02M. Therefore, the gross margin over that period was 97.3%.
RMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, ResMed Inc. reported a gross profit of 878.72M and revenue of 1.42B. Therefore, the gross margin over that period was 61.8%.
GERN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Geron Corporation reported an operating income of -10.79M and revenue of 48.02M, resulting in an operating margin of -22.5%.
RMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, ResMed Inc. reported an operating income of 491.66M and revenue of 1.42B, resulting in an operating margin of 34.6%.
GERN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Geron Corporation reported a net income of -31.14M and revenue of 48.02M, resulting in a net margin of -64.9%.
RMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, ResMed Inc. reported a net income of 392.59M and revenue of 1.42B, resulting in a net margin of 27.6%.